NCT01544244

Brief Summary

The primary objective of this study is to demonstrate the superiority of the CGE physical therapy protocol versus a standard physical therapy protocol of the shoulder by measuring the following after 1 month of physical therapy: the FI2S score including validated measures of pain, glenohumeral joint range of motion in the three planes, the ability to perform certain everyday activities and the strength of forward elevation measured with a dynamometer.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2012

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 23, 2012

Completed
11 days until next milestone

First Posted

Study publicly available on registry

March 5, 2012

Completed
7 months until next milestone

Study Start

First participant enrolled

October 1, 2012

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2016

Completed
Last Updated

June 3, 2016

Status Verified

June 1, 2016

Enrollment Period

3.6 years

First QC Date

February 23, 2012

Last Update Submit

June 2, 2016

Conditions

Keywords

comparison of physical therapy strategies

Outcome Measures

Primary Outcomes (1)

  • change in FI2S score

    90 days

Secondary Outcomes (23)

  • Change in visual analog scale for pain

    Day 1 versus baseline

  • Change in visual analog scale for pain

    Day 5 versus baseline

  • Change in visual analog scale for pain

    Day 12 versus baseline

  • Change in visual analog scale for pain

    Day 19 versus baseline

  • Change in visual analog scale for pain

    Day 26 versus baseline

  • +18 more secondary outcomes

Study Arms (2)

GSC physcial therapy

EXPERIMENTAL

Patients included in this arm of the study will follow the Global Shoulder Concept physical therapy sequence.

Procedure: GSC physical therapy

Standard

ACTIVE COMPARATOR

Patients in this arm of the study will follow the standard physical therapy sequence.

Procedure: Standard physical therapy

Interventions

Global Shoulder Concept physical therapy sequence for shoulder tendonitis. The procedures used in this protocol refer to physical therapy sequences, not to devices or drugs.

GSC physcial therapy

Standard physical therapy sequence for shoulder tendonitis. The procedures used in this protocol refer to physical therapy sequences, not to devices or drugs.

Standard

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The patient must have given his/her informed and signed consent
  • The patient must be insured or beneficiary of a health insurance plan
  • painful, chronic tendinopathy (more than 3 months) of the rotator cuff, confirmed by MRI

You may not qualify if:

  • The patient is pregnant or breastfeeding
  • Any emergency situation
  • Non-mechanical tendinopathies (metabolic, neurological, capsulitis, reflex sympathetic dystrophy) and tendon surgery (tendon surgery and acromioplasty)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

CHU de Montpellier - Hôpital Lapeyronie

Montpellier, 34295, France

Location

CHU de Nîmes - Hôpital Universitaire Carémeau

Nîmes, 30029, France

Location

MeSH Terms

Conditions

Tendinopathy

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesTendon InjuriesWounds and Injuries

Study Officials

  • Dominique Richard

    Centre Hospitalier Universitaire de Nîmes

    STUDY DIRECTOR
  • Arnaud Dupeyron, MD PhD

    Centre Hospitalier Universitaire de Nîmes

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 23, 2012

First Posted

March 5, 2012

Study Start

October 1, 2012

Primary Completion

May 1, 2016

Study Completion

May 1, 2016

Last Updated

June 3, 2016

Record last verified: 2016-06

Locations